Leukemia - Multiple Myeloma Exosome |
P141-MM |
101Bio |
- |
Ask for price |
Human IgG antibody Laboratories manufactures the igm spike multiple myeloma reagents distributed by Genprice. The Igm Spike Multiple Myeloma reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike IgM. Other Igm products are available in stock. Specificity: Igm Category: Spike Group: Multiple Myeloma
Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
AcceGen |
1 vial |
Ask for price |
|
Description: Multiple Myeloma-Bone Marrow Plasma is obtained by centrifuging the Multiple Myeloma-bone marrow. The plasma has a diminished number of cells and platelets. Multiple Myeloma-Bone Marrow plasma is available in both the newly diagnosed and relapsed/refractory stages. |
Human Multiple Myeloma Peripheral Blood Mononuclear Cells (Relapsed/Refractory) |
AcceGen |
1 vial |
Ask for price |
|
Description: Multiple Myeloma Peripheral Blood Mononuclear Cells are isolated from Multiple Myeloma-peripheral blood by diluting the blood with phosphate-buffered salineand using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Multiple Myeloma PBMCs products are available in both the newly diagnosed and the relapsed/refractory stages. |
HighQC™ Human Multiple Myeloma (MM) Cancer Stem Cell |
AcceGen |
1 vial |
Ask for price |
Description: Human Multiple Myeloma (MM) Cancer Stem Cell; Frozen Vial and Plated cells are available. Cells are only guaranteed with purchase of Gentaur Media and Gentaur Extra Cellular Matrix for appropriate cell culture, for 30 days from the date of shipment. |
Recombinant Human Multiple myeloma tumor-associated protein 2 (MMTAG2) |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1145 |
Recombinant Human Multiple myeloma tumor-associated protein 2 (MMTAG2) |
MyBiosource |
0.02mg(E-Coli) |
EUR 780 |
Recombinant Human Multiple myeloma tumor-associated protein 2 (MMTAG2) |
MyBiosource |
0.02mg(Yeast) |
EUR 935 |
Recombinant Human Multiple myeloma tumor-associated protein 2 (MMTAG2) |
MyBiosource |
0.1mg(E-Coli) |
EUR 935 |
Multiple Myeloma information
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (MaxLight 490) |
MBS6323259-01mL |
MyBiosource |
0.1mL |
EUR 980 |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (MaxLight 490) |
MBS6323259-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (MaxLight 550) |
MBS6323260-01mL |
MyBiosource |
0.1mL |
EUR 980 |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (MaxLight 550) |
MBS6323260-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (MaxLight 650) |
MBS6323261-01mL |
MyBiosource |
0.1mL |
EUR 980 |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (MaxLight 650) |
MBS6323261-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (MaxLight 750) |
MBS6323262-01mL |
MyBiosource |
0.1mL |
EUR 980 |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (MaxLight 750) |
MBS6323262-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated) |
ABC-TC3952 |
AcceGen |
1 vial |
Ask for price |
|
Description: Multiple Myeloma-PB-Plasma is obtained by centrifugation of Multiple Myeloma peripheral blood. Plasma has a diminished number of cells. Multiple Myeloma-PB-Plasma is available in both the newly diagnosed and relapsed/refractory stages. |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (Azide free) (HRP) |
MBS6323257-02mL |
MyBiosource |
0.2mL |
EUR 980 |
MYEOV, ID (MYEOV, OCIM, Myeloma-overexpressed gene protein, Oncogene in multiple myeloma) (Azide free) (HRP) |
MBS6323257-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
Human Multiple Myeloma Bone Marrow Plasma (Relapsed/Refractory) |
ABC-TC3949 |
AcceGen |
1 vial |
Ask for price |
|
Description: Multiple Myeloma-Bone Marrow Plasma is obtained by centrifuging the Multiple Myeloma-bone marrow. The plasma has a diminished number of cells and platelets. Multiple Myeloma-Bone Marrow plasma is available in both the newly diagnosed and relapsed/refractory stages. |
Multiple Myeloma Tumor-Associated Protein 2 (MMTAG2) Antibody |
20-abx133575 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Multiple Myeloma Tumor-Associated Protein 2 (MMTAG2) Antibody |
20-abx013775 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
Multiple Myeloma Tumor-Associated Protein 2 (MMTAG2) Antibody |
abx013775-100l |
Abbexa |
100 µl |
EUR 43.75 |
Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
ABC-TC3948 |
AcceGen |
1 vial |
Ask for price |
|
Description: Multiple Myeloma-Bone Marrow Plasma is obtained by centrifuging the Multiple Myeloma-bone marrow. The plasma has a diminished number of cells and platelets. Multiple Myeloma-Bone Marrow plasma is available in both the newly diagnosed and relapsed/refractory stages. |
Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed) |
ABC-TC3945 |
AcceGen |
1 vial |
Ask for price |
|
Description: Multiple Myeloma-Bone Marrow-Mononuclear Cells are isolated by diluting Multiple Myeloma-bone marrow with phosphate-buffered saline and using gradient separation. Multiple Myeloma Bone Marrow-Mononuclear Cells products are available in both the newly diagnosed and relapsed/refractory stages. |